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Abstract
Several individual components of the Mediterranean diet have been shown to offer protection against prostate cancer. The present study is the ﬁrst to
investigate the association between adherence to the Mediterranean diet and the relative risk of prostate cancer. We also explored the usefulness of the
Mediterranean Diet Score (MDS) in a non-Mediterranean population. FFQ data were obtained from 1482 incident prostate cancer patients and 1108 popu-
lation-based controls in the Cancer of the Prostate in Sweden (CAPS) study. We deﬁned ﬁve MDS variants with different components or using either
study-speciﬁc intakes or intakes in a Greek reference population as cut-off values between low and high intake of each component. Unconditional logistic
regression was used to estimate the relative risk of prostate cancer for high and medium v. low MDS, as well as potential associations with the individual
score components. No statistically signiﬁcant association was found between adherence to the Mediterranean diet based on any of the MDS variants and
prostate cancer risk (OR range: 0·96–1·19 for total prostate cancer, comparing high with low adherence). Overall, we found little support for an association
between the Mediterranean diet and prostate cancer in this Northern European study population. Despite potential limitations inherent in the study or in
the build-up of a dietary score, we suggest that the original MDS with study-speciﬁc median intakes as cut-off values between low and high intake is useful
in assessing the adherence to the Mediterranean diet in non-Mediterranean populations.
Key words: Prostatic neoplasms: Dietary patterns: Dietary score: Epidemiology
Prostate cancer is the second most common cancer among men
globally and is the most common cancer in high-income
countries
(1). However, its incidence varies considerably in differ-
ent parts of the world. The highest incidence is seen in the
Nordic countries, North America, Australia and New Zealand,
with age-standardised rates ranging from seventy-three to 112
per 100 000 person-years
(1). In most Mediterranean countries,
the incidence rates are almost half to two-thirds lower
(1),
suggesting that certain aspects of the Mediterranean lifestyle
may be associated with a reduced incidence of prostate cancer.
A number of epidemiological studies suggest that a
Mediterranean dietary pattern may offer protection against sev-
eral types of cancer
(2,3). The traditional Mediterranean diet is
the dietary habit typical of the Mediterranean regions, notably
Abbreviations: CAPS, Cancer of the Prostate in Sweden; MDS, Mediterranean Diet Score; MP:S, MUFA and PUFA to SFA.
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1Crete and other parts of Greece, southern Italy and Spain, in
the period before the 1960s. The general features of this diet
are high intake of vegetables, fruits, nuts, beans, cereals and
lean ﬁsh, together with high consumption of olive oil, moderate
consumption of alcohol (especially wine with meals) and low
amounts of milk and red meat. Several of these individual
food items, or the nutrients they contain, have been associated
with a reduced risk of prostate cancer
(4). Based on previous
knowledge about the effect of Mediterranean dietary com-
ponents, Trichopoulou et al.
(5) estimated that shifting to a tra-
ditional Mediterranean diet could prevent up to 10 % of the
prostate cancer cases in Western high-income countries.
Several dietary scores have been developed to assess adher-
ence to the Mediterranean diet
(6). In 1995, Trichopoulou
et al.
(7) developed the Mediterranean Diet Score (MDS) based
on eight dietary components: the intake of vegetables, fruits
and nuts, legumes, cereals, meat, dairy products and alcohol,
as well as the ratio of MUFA to SFA. Fish was added as a
ninthcomponentin2003
(8).TheMDSandseveralmodiﬁedver-
sionshavebeenusedinepidemiologicalstudiesofvarioushealth
outcomes,bothinMediterraneanandnon-Mediterraneanpopu-
lations
(6,9,10). An important component of the traditional
Mediterranean diet is olive oil, resulting in a high ratio of
MUFA to SFA. Outside the Mediterranean region olive oil is
consumed less frequently, and the intake of MUFA is not only
considerably lower, but mainly originates from a higher meat
intake rather than from vegetable oils. In an attempt to adapt
the MDS for use in non-Mediterranean populations, the fat
ratio component has been modiﬁed so as to include both
MUFA and PUFA in the numerator
(11,12). Moreover, the cut-off
value between high and low intake for each MDS component is
the median intake in the population under study. However, using
the median intake in a non-Mediterranean study population may
be questionable, as the intake of certain components may be
much lower or higher than that in a typical Mediterranean popu-
lation. Thus the score may be less able to discriminate between
intake levels that are beneﬁcial or non-beneﬁcial to health.
In the present study, we investigated the association between
the Mediterranean diet and the relative risk of prostate cancer
in a Swedish population. In order to examine the potential
effect of using study-speciﬁc median intakes in a
non-Mediterranean population as cut-off values in the MDS,
we developed several variants of the score using both intakes
in the Swedish study population and in a Greek reference
population
(8) as cut-off values. We also created an alternative
score that more closely reﬂects the traditional Mediterranean
diet, directed towards its most beneﬁcial components.
Furthermore, we explored the potential effect measure modi-
ﬁcation by selected covariates. To the best of our knowledge,
this is the ﬁrst study speciﬁcally investigating prostate cancer
risk and the Mediterranean diet using a dietary score.
Experimental methods
Study population
The Cancer of the Prostate in Sweden (CAPS) study is a
population-based case–control study on prostate cancer and
has been described in detail previously
(13–15). Brieﬂy, incident
and histologically conﬁrmed prostate cancer cases were ident-
iﬁed from four of the six regional cancer registries in Sweden
and were invited to take part in the study. Cases were 35–79
years old at enrolment, from January 2001 to September
2002, and lived in the central and northern parts of Sweden.
For 95 % of the cases, clinical data were obtained from the
National Prostate Cancer Registry. Advanced cases were
deﬁned as those meeting at least one of the following criteria:
tumour, nodes, metastasis stage T3/T4 or N1 or M1; Gleason
score 8–10; or serum prostate-speciﬁc antigen level at diagno-
sis ≥100 ng/ml. Localised cases were deﬁned as those with
T1/T2, N0, M0, Gleason score 2–6 and prostate-speciﬁc anti-
gen <20 ng/ml. Cases with Gleason score 7 who did not meet
the criteria for advanced disease were included in neither
advanced nor localised cases due to the difference in aggres-
siveness seen for Gleason 3 + 4 compared with Gleason
4+3
(16). Controls were selected randomly from the Swedish
Population Registry every 6 months, being frequency-matched
to cases by age in 5-year categories and region of residence.
Invitations to participate were sent out to eligible controls
about once a month, except July and August, to reﬂect the
continuous enrolment of cases.
All study participants were asked to complete a baseline
questionnaire. The number of cases ﬁlling in the questionnaire
was 1499 (79 %) out of 1895 invited and the corresponding
number for controls was 1130 (67 %) out of 1684 invited.
The average time between diagnosis and sending out the ques-
tionnaire was 5 months. The study was performed according
to the guidelines laid down in the Declaration of Helsinki
and was approved by the ethics committees at Karolinska
Institutet and Umeå University in Sweden. Written informed
consent was obtained from all participants.
Exposure assessment
Usual dietary intake over the past year was assessed using a
semi-quantitative FFQ with 106 items, including foods, bev-
erages and alcohol, and with three additional questions on
dietary fat, including a question on regular use of olive oil
for cooking and/or in dressings (yes/no)
(13,14,17,18). The intake
of several food items assessed with a shorter version of the
FFQ has been validated against four 7 d weighed food records
in 111 randomly sampled Swedish women, giving Spearman
correlation coefﬁcients in the range 0·16–0·82 (e.g. 0·30–
0·37 for vegetables/tomatoes, 0·38–0·49 for fruit/fruit juice,
0·16–0·61 for reﬁned grains/whole grains/cereals, 0·44 for
ﬁsh, 0·44 for dairy products, 0·37–0·60 for meat/poultry
and 0·56–0·82 for alcoholic beverages)
(19). Although the vali-
dation was performed in women, the results are likely to be
similar in men
(20,21). The intake of nutrients has been validated
against fourteen repeated 24-h recall interviews in 248 ran-
domly sampled Swedish men, showing Spearman correlation
coefﬁcients in the range 0·25–0·81 (e.g. 0·75 for SFA, 0·66
for MUFA, 0·49 for PUFA and 0·81 for ethanol)
(22). The
energy intake assessed by the FFQ was within 8 % of the esti-
mated intake from the 24 h recalls in the same validation
study. To calculate nutrient and energy intakes, we created
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items, and linked the dietary data from the questionnaire to
the Swedish National Food Administration database
(23), com-
prising about 1500 food products.
The questionnaire also contained questions regarding known
and potential lifestyle risk factors for prostate cancer, such as
physical activity, tobacco use, height, weight, education, occu-
pation, marital status, history of diabetes and family history
of cancer (prostate or other). The questions on physical activity
included occupational activity, walking/bicycling, exercise and
household/leisure-time activity at age 15, 30, 50 and 65
years. They have been validated against two 7 d activity diaries
in 111 men (Spearman correlation r 0·56)
(24). Physical activity
level was calculated as metabolic equivalent by multiplying
the reported time in h/d for each activity by the assigned meta-
bolic equivalent value, given in appendix 1 of the publication by
Norman et al.
(24). Only activities of moderate or vigorous inten-
sity (metabolic equivalent≥3) were used
(25). We calculated the
lifetime physical activity by taking the mean value over all ages.
The Mediterranean Diet Score
We created ﬁve variants of the MDS originally developed by
Trichopoulou et al.
(7,8), as listed in Table 1. The main score,
denoted as MDS-gram, is based on nine components: a high
ratio of MUFA and PUFA to SFA (MP:S); high vegetable
intake (including tomato juice, ketchup and root vegetables,
except potatoes); high intake of fruit, nuts and seeds; high
legume intake; high cereal intake; high ﬁsh and seafood intake;
low intake of dairy products; low intake of meat and meat pro-
ducts (including poultry); and moderate alcohol intake.
Frequencies of intake from the questionnaire were translated
into intakes in g/d using standard portion sizes
(26). All intakes
were energy-adjusted by dividing the actual food intake by the
individual’s total energy intake and multiplying by 10 460 kJ
(equivalent to 2500 kcal)
(7). A score of zero or one was
assigned to each component using the median intake among
the controls in g/d as cut-off between low and high intake.
For beneﬁcial components (the ﬁrst six listed previously),
one point was given for intakes at or above the median and
zero points otherwise. For the milk and meat components,
one point was given for intakes below the median and zero
points otherwise. For alcohol (ethanol), one point was given
for intakes above zero and below the median intake, and zero
points otherwise. A total score ranging from zero to nine points
was calculated by summing up the scores of the individual com-
ponents. The total score was then categorised into low (zero to
three points), medium (four to ﬁve points) or high (six to nine
points) adherence to the Mediterranean diet based on the
approximate tertile distribution among the controls.
A total of three score variants were created based on the
same components as MDS-gram, but with different cut-off
values between low and high intake of each component. In
MDS-serv, we used the study-speciﬁc median intakes
(among the controls) expressed as servings/week instead of
g/d as cut-off values, assuming that one serving of a food
item has the same impact no matter the serving size. In
MDS-cent, the study-speciﬁc twenty-ﬁfth or seventy-ﬁfth
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journals.cambridge.org/jnscentiles of the intake (in g/d) were used as cut-off values instead
of the median intake; the centile level for each component was
chosen so as to achieve cut-off values that were close to the
median intakes in the Greek reference population, while main-
taining a sufﬁcient number of participants in the extreme
groups. In MDS-greek, the median intakes (in g/d) in the afore-
mentioned Greek reference population were used as cut-off
values; however, for vegetable and fruit/nut intake we used
the ninetieth centile of the intake in the CAPS population
since very few participants reached the Greek median intake
levels. MDS-serv and MDS-cent were categorised using the
same adherence cut-off values as MDS-gram, whereas MDS-
greek was categorised as low (zero to two points), medium
(three to four points), or high (ﬁve to nine points) adherence.
Lastly, we created an alternative score, denoted as MDS-alt,
with a focus on the most ‘traditional’ components of the
Mediterranean diet. This score was based on ten components,
basically the same as in the other score variants except that the
fat ratio was replaced by olive oil use, cereals by whole grains,
meat by red/processed meat, ethanol by red wine and fruits
and nuts/seeds were separated into two components. Similar
variants of the MDS have been used in other studies
(27–30).
Olive oil use was added as a separate component since it
was not included in the nutrient calculations for fat, due to
the design of the questionnaire in the CAPS study (yes/no,
no frequency reported). The study-speciﬁc median intake in
g/d was used as the cut-off between low and high intake of
each component. The total MDS-alt ranging from zero to
ten points was categorised into low (zero to three points),
medium (four to ﬁve points) or high (six to ten points) adher-
ence to the Mediterranean diet.
Statistical methods
We excluded men with incomplete dietary data (n 67) or unrea-
sonably high or low energy intakes (<3300 kJ/d or >21 000
kJ/d) (n 27). In total, 2590 participants (1482 cases and
1108 controls) were included in the ﬁnal analyses. Baseline
characteristics of cases and controls were compared using
the Wilcoxon–Mann–Whitney test for continuous variables
and the χ
2 test for categorical variables. Correlations between
the continuous MDS variants and their components were eval-
uated by estimating Spearman correlation coefﬁcients.
Unconditional logistic regression was used to generate OR
with 95 % CI, as estimates of the relative risk of prostate can-
cer according to adherence to the Mediterranean diet.
Adherence to each MDS variant was analysed using indicator
variables for low, medium and high score, with low as the
reference group. Additionally, the scores were modelled as
continuous variables, ﬁrstly by assessing the linear effect of a
one-point increment in the score on prostate cancer risk and
secondly by ﬁtting restricted cubic splines to relax the linear
assumption and to create smoothed functions of adherence
to the scores. Moreover, we evaluated the individual effects
of each MDS component. All analyses were performed for
total prostate cancer, for advanced (n 588) and localised
(n 512) disease, as well as for Gleason score 7 disease subtype
(n 218).
Simple regression models included the matching factors: age
and region of residence. Multivariate regression models
additionally included education, smoking, BMI, energy intake,
physical activity, history of diabetes and family history of
prostate cancer. Potential confounders were selected based
on subject matter knowledge as well as on indications pro-
vided by purely statistical procedures, such as a change in
β-coefﬁcients (>10 %). Other covariates that were considered
as potential confounders but not included in the ﬁnal model
were height, employment status, marital status, snuff use,
use of dietary supplements, use of olive oil and intake of cof-
fee, phyto-oestrogens, potatoes, sweet foods and non-alcoholic
beverages. The potential effect measure modiﬁcation by
selected covariates (age, family history of prostate cancer, his-
tory of diabetes and BMI) was evaluated in two ways: formal
interaction tests by including multiplicative interaction terms in
logistic regression models, and by the use of interaction indi-
cator variables to obtain a stratiﬁed effect.
Wald and likelihood ratio tests were used to assess the stat-
istical signiﬁcance of observed associations (P <0·05, two-
sided tests). The ﬁt of the models was evaluated by the
Hosmer–Lemeshow and the Pearson χ
2 goodness-of-ﬁt
tests. All analyses were performed using the statistical software
systems SAS version 9.2 (SAS Institute Inc.) and Stata version
12 (StataCorp LP).
Results
The study population is described in Table 2. The cases were
somewhat younger than the controls and were more likely to
reside in the northern part of Sweden, to be employed,
to take dietary supplements and to have a family history of
prostate cancer. Cases and controls also differed with regard
to their intake of total energy, alcohol, non-alcoholic bev-
erages, tomatoes and sweet foods, but there were no major
differences concerning BMI, level of education, marital status,
smoking status, physical activity, coffee intake or potato intake.
The differences observed for the matching factors age and
region of residence may be explained by the lower participation
rate among controls than among cases, and was apparent already
before exclusion of participants (n 94) (results not shown).
The mean total score of each of the ﬁve MDS variants, as
well as the distribution between the three adherence groups, is
given in Table 3. The results were in general similar for cases
and controls, except for a slightly higher mean of MDS-serv,
MDS-cent and MDS-alt among the cases. The mean total
score of MDS-gram was 4·4( SD 1·7) among both cases and
controls: 31 % of cases and 33 % of controls had low adher-
ence, 42 % of cases and 40 % of controls had medium adher-
ence and 27 % of both cases and controls had high adherence.
Table 4 presents the intake levels of the MDS components
and of the total energy, macronutrients and selected food
items, in the CAPS population as well as in the Greek refer-
ence population. The intake of vegetables and fruits was con-
siderably lower in the Swedish population, whereas the intake
of legumes, cereals, ﬁsh and dairy products was higher than
that in the Greek population. The intake of meat was similar
in both populations. As expected, the MP:S ratio in the
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Cases (n 1482) Controls (n 1108)
Characteristics n %† n %† P*
Age (years) <0·01
Mean 66·86 7 ·7
SD 7·37 ·5
Region of residence <0·01
Northern Sweden 455 31 197 18
Central Sweden 1027 69 911 82
Education level 0·15
0–9 years 675 46 506 46
10–12 years 595 40 468 42
≥13 years 207 14 127 11
Marital status 0·25
Married/partner 1200 81 867 78
Divorced/unmarried 204 14 165 15
Widower 77 5 71 6
History of diabetes 0·62
Yes 171 12 134 12
No 1292 87 953 86
Family history of prostate cancer <0·01
Yes 273 18 103 9
No 1209 82 1005 91
Smoking 0·44
Never smoker 575 39 424 38
Former smoker 734 49 535 48
Current smoker 156 11 134 12
Dietary supplement use <0·01
Yes 702 47 437 39
No 737 50 623 56
BMI at inclusion (kg/m
2) 0·44
<25 574 39 400 36
25 to <30 686 46 526 47
≥30 177 12 141 13
Physical activity (MET-h/d)‡ 0·94
Mean 12·71 2 ·8
SD 8·99 ·1
Total energy intake (kJ/d) <0·01
Mean 9583·5 9303·9
SD 2670·2 2721·1
Alcohol intake (g/d) <0·01
Mean 8·28 ·0
SD 16·81 9 ·9
Non-alcoholic beverage intake (servings/d) <0·01
Mean 1·00 ·9
SD 1·21 ·2
Coffee intake (cups/d) 0·67
Mean 3·13 ·1
SD 1·92 ·0
Tomato intake (servings/d) <0·01
Mean 0·40 ·4
SD 0·30 ·3
Potato intake (servings/d) 0·19
Mean 0·50 ·5
SD 0·30 ·3
Sweet foods intake (servings/d)§ <0·01
Mean 0·80 ·8
SD 0·50 ·5
Disease characteristics among cases (% of all cases) –
Advanced  588 40 ––
Localised¶ 512 34 ––
Gleason score 7 218 15 ––
Unknown 87 6 ––
Other 77 5 ––
Gleason score –
Mean 6·5 –
SD 1·2 –
Continued
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journals.cambridge.org/jnsSwedish population was lower than the MUFA:SFA ratio in
the Greek population. The intake of SFA was similar in
both populations, whereas the intake of MUFA and PUFA,
as well as the total energy, was lower in the Swedish popu-
lation. The Swedish population ate more potatoes and sweet
foods but drank less non-alcoholic beverages than the Greek
population. The correlation between individual components
and the main score, MDS-gram, was low to moderate, ranging
from rs 0·07 for ethanol to rs 0·58 for vegetables. Similarly, the
individual components of the alternative score, MDS-alt, were
weakly or moderately correlated with the total score (range rs
0·05–0·46). Inter-correlation between the individual com-
ponents was in the range rs 0·02–0·40 (results not shown).
The correlation coefﬁcients between the MDS variants ranged
from 0·43 between MDS-serv and MDS-greek, to 0·79
between MDS-gram and MDS-serv and between MDS-gram
and MDS-alt, respectively (results not shown).
As shown in Fig. 1, no statistically signiﬁcant association
was found between any of the MDS variants and prostate can-
cer. However, high MDS-cent, MDS-greek and MDS-alt
scores seemed to be associated with a 20–35 % increased rela-
tive risk of advanced prostate cancer, compared with low
scores, and a somewhat weaker increased risk of total prostate
cancer. However, the estimates were not statistically signiﬁcant
and the CI were wide. For cases with Gleason score 7, a non-
statistically signiﬁcant inverse association was seen for high v.
low MDS-gram and MDS-serv (multivariate OR were 0·84,
95 % CI 0·59, 1·19; and 0·77, 95 % CI 0·55, 1·09, respectively;
results not shown). No association was seen between Gleason
score 7 disease subtype and any of the other MDS-variants.
There was no evidence of an association between the continu-
ous scores and prostate cancer, in neither logistic regression
models nor restricted cubic spline regression models, except
for a non-signiﬁcant positive association between the total
prostate cancer and MDS-cent (results not shown).
Among the individual score components, a high vegetable
intake was associated with an increased risk of prostate cancer,
with multivariate OR 1·25 (95 % CI 1·05, 1·50; Ptrend=0·01)
for total prostate cancer, 1·37 (95 % CI 1·09, 1·72; Ptrend=
0·006) for advanced disease and 1·25 (95 % CI 0·98, 1·60;
Ptrend=0·07) for localised disease (results not shown). In sup-
plementary analyses, the positive association remained but was
weakened when tomatoes were excluded from vegetable
intake, and a high intake of tomato products was found to
be positively associated with localised disease (multivariate
OR 1·25; 95 % CI 0·99, 1·59; Ptrend=0·07) compared with
low intake. A high ethanol intake was associated with an
increased risk of advanced prostate cancer (multivariate OR
1·25; 95 % CI 0·99, 1·58; Ptrend=0·06). Simple models
Table 2. Continued
Cases (n 1482) Controls (n 1108)
Characteristics n %† n %† P*
PSA level (ng/ml) –
Mean 88·4 –
SD 360·4 –
MET, metabolic equivalent; PSA, prostate-specific antigen.
* Two-sided P values estimated using the χ
2 test for categorical variables and the Wilcoxon–Mann–Whitney test for continuous variables.
† Percentage of all cases and of all controls, respectively. Column percentages do not always add up to 100 due to missing data.
‡ Activity of at least moderate intensity (MET≥3).
§ Includes confectionery, sweet bakery products and ice cream.
║Meeting at least one of the following criteria: tumour stage T3/T4 or N1 or M1; or Gleason score 8–10; or PSA≥100 ng/ml.
¶ Meeting all of the following criteria: tumour stage T1/T2, N0, M0, Gleason score 2–6 and PSA< 20 ng/ml.
Table 3. Adherence to the Mediterranean Diet Score (MDS) variants in
cases and controls in the Cancerof the Prostate in Sweden (CAPS) study*
(Mean values and standard deviations; number of participants and
percentages)
Cases
(n 1482)
Controls
(n 1108)
Characteristics n %† n %†
MDS-gram (points)
Mean 4·44 ·4
SD 1·71 ·7
MDS-serv (points)
Mean 4·44 ·3
SD 1·71 ·7
MDS-cent (points)
Mean 4·24 ·1
SD 1·51 ·5
MDS-greek (points)
Mean 3·33 ·3
SD 1·21 ·1
MDS-alt (points)
Mean 4·64 ·5
SD 1·91 ·9
Adherence to MDS-gram
Low (0–3 points) 460 31 360 33
Medium (4–5 points) 621 42 445 40
High (6–9 points) 401 27 303 27
Adherence to MDS-serv
Low (0–3 points) 482 33 359 32
Medium (4–5 points) 600 40 456 41
High (6–9 points) 400 27 293 27
Adherence to MDS-cent
Low (0–3 points) 493 33 387 35
Medium (4–5 points) 723 49 517 47
High (6–9 points) 266 18 204 18
Adherence to MDS-greek
Low (0–2 points) 339 23 262 24
Medium (3–4 points) 939 63 703 63
High (5–9 points) 204 14 143 13
Adherence to MDS-alt
Low (0–3 points) 449 30 367 33
Medium (4–5 points) 524 36 405 37
High (6–10 points) 509 34 336 30
* For details of the MDS variants, see Table 1.
† Percentage of all cases and of all controls, respectively.
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journals.cambridge.org/jnsshowed an inverse association for a high MP:S ratio, but the
association disappeared after adjusting for potential confoun-
ders. A high meat intake was associated with a 10–15 %
reduction in prostate cancer risk in multivariate models,
although this was not statistically signiﬁcant. No association
was found between the intake of fruits and nuts, legumes, cer-
eals, ﬁsh or dairy products and prostate cancer. The results for
Gleason score 7 disease subtype were in the same direction as
for total prostate cancer (results not shown). As illustrated in
Fig. 2, smoothed functions of intake showed weak positive
associations between total prostate cancer and the MP:S ratio,
vegetable intake and fruit/nut intake, although the CI included
the value of 1. A dose–response trend was suggested for the
association with the MP:S ratio. A high intake of legumes,
ﬁsh and meat was possibly associated with a non-signiﬁcant
reduced risk of prostate cancer, whereas no association was
observed for cereals, dairy products or alcohol.
Analysis of components speciﬁc to the MDS-alt showed an
inverse association between a high intake of red/processed
meat and total prostate cancer (multivariate OR 0·83; 95 %
CI 0·70, 0·99; Ptrend=0·04). The results were similar but non-
statistically signiﬁcant in the case of advanced and localised
disease. We observed an increased risk of advanced disease
for a high intake of red wine (multivariate OR 1·39; 95 %
CI 1·06, 1·82; Ptrend=0·02). No statistically signiﬁcant associ-
ations were seen for olive oil use, whole grains, fruit or nuts.
Tests for potential interactions between the Mediterranean
diet (MDS-gram) and selected covariates showed no statistically
signiﬁcantinteractions(resultsnotshown).However,whendata
were stratiﬁed using interaction indicator variables, men with a
family historyof prostate cancer hada non-signiﬁcant increased
risk of total prostate cancer (OR 1·67; 95 % CI 0·87; 3·22;
Pinteraction =0·29) comparing high with low MDS-gram, which
was not seen in men without a family history of the disease;
this possible interaction was even more pronounced foradvanced
disease (OR 2·42; 95 % CI 1·10, 5·34; Pinteraction=0·10).
Furthermore, stratiﬁed analyses showed a positive association
between the Mediterranean diet and prostate cancer among
obese men (BMI≥30 kg/m
2), with multivariate OR 2·06 (95 %
CI 1·11, 3·81; Pinteraction=0 ·09) for total malignancy, 2·17 (95 %
CI 0·99, 4·76; Pinteraction=0·24) for advanced disease and 1·94
(95 % CI 0·84, 4·49; Pinteraction=0 ·48) for localised disease, but
not among men with BMI < 30 kg/m
2. Age at inclusion and
diabetes did not act as effect modiﬁers in the present study.
Discussion
Overall, we found no association between the Mediterranean
diet and relative risk of prostate cancer. Among individual
score components, a high intake of vegetables and alcohol
was associated with an increased risk of prostate cancer, and
a high intake of red/processed meat with a decreased risk of
Fig. 1. Relative risk of total (n 2336), advanced (n 1494) and localised (n 1441) prostate cancer (PC) according to adherence to the Mediterranean Diet Score (MDS)
variants: (a) MDS-gram, (b) MDS-serv, (c) MDS-cent, (d) MDS-greek and (e) MDS-alt. For details of the MDS variants, see Table 1. Estimates reflect OR (95 % CI)
derived from unconditional logistic regression models. All models are adjusted for age (in 5-year intervals), region of residence (north/central), education (0–9 years;
10–12 years; ≥13 years), smoking status (never/former/current), BMI (quartile distribution of controls), energy intake (quartile distribution of controls), physical activity
(quartile distribution of controls), history of diabetes (yes/no) and family history of prostate cancer (yes/no). Adherence groups were categorised as follows: (a–c) low
adherence, 0–3 points (reference); medium adherence, 4–5 points; high adherence, 6–9 points; (d) low adherence, 0–2 points (reference); medium adherence, 3–4
points; high adherence, 5–9 points; (e) low adherence, 0–3 points (reference); medium adherence, 4–5 points; high adherence, 6–10 points.
8
journals.cambridge.org/jnsthe disease. The association between MDS and prostate cancer
was indicated as positive in obese men and in men with a
family history of the disease.
To the best of our knowledge, no other studies have so far
been carried out on the association between the Mediterranean
dietary pattern and prostate cancer using a dietary score. A few
studies looking at empirically derived dietary patterns have
shown an increased risk of prostate cancer with ‘Western’ diet-
ary patterns rich in meat and processed foods
(31–33), i.e. foods
consumed at low amounts in the traditional Mediterranean
diet. Interestingly, Greek migrants in Australia have a lower
risk of prostate cancer than men born in Australia, and they
have also retained the dietary habits of their native country,
as opposed to many other migrant populations
(4). Studies on
the Mediterranean diet and overall cancer risk have shown
inconsistent results
(2,3). A meta-analysis of data from seven
cohort studies provided a pooled relative risk of cancer of
0·94 (95 % CI 0·92, 0·96) for a two-point increase in the
MDS
(9). In a recent review, the Mediterranean diet was con-
sidered as ‘probably’ protective against overall cancer, albeit
there is variation with regard to different cancer sites
(3).
Although the Mediterranean diet as a whole has not pre-
viously been studied in relation to prostate cancer, its individ-
ual components have. Recent reviews suggest that a high
intake of vegetables, marine fatty acids, legumes and foods
containing vitamin E (such as vegetable oils, nuts and seeds)
may offer protection against the disease
(4,34–37), and a favour-
able effect may also be seen with a low intake of meat and
foods rich in Ca such as dairy products
(4,35–38). In theory,
the combined effect of these components may be beneﬁcial
in prostate cancer prevention.
In the present study, the observed positive association
between a high vegetable intake and prostate cancer is unex-
pected, considering earlier indications of an inverse associ-
ation
(34,36). The main contributors to the vegetable intake
were tomatoes, carrots and mixed vegetables, each contribut-
ing on average 14–16 %. A high intake of tomatoes, notably
tomato sauce, has been shown in several studies to reduce
the risk of prostate cancer
(34,37,39). The indicated positive
association between tomato intake and localised disease in
our study may be explained by localised cases potentially
being more health conscious and more likely to eat healthier.
Fig. 2. Dose–response relationship between components of the Mediterranean Diet Score (MDS-gram; see Table 1 for details) and relative risk of total prostate
cancer (n 2336): (a) MUFA and PUFA to SFA (MP:S) ratio, (b) vegetables, (c) fruits and nuts, (d) legumes, (e) cereals, (f) fish, (g) meat and meat products, (h)
dairy products and (i) alcohol. Results from restricted cubic regression splines with five knots. (–––), OR; (----), 95 % CI. The CI cross at the reference point, equiv-
alent to the tenth centile of the intake in the study population. Regression models include age (in 5-year intervals), region of residence (north/central), education (0–9
years; 10–12 years; ≥13 years), smoking status (never/former/current), BMI (quartile distribution of controls), energy intake (quartile distribution of controls), physical
activity (quartile distribution of controls), history of diabetes (yes/no) and family history of prostate cancer (yes/no).
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for advanced disease and remained, although weakened, when
tomatoes were excluded from the vegetable intake. Also, the
vegetable intake was much lower in the study population
than in the Greek reference population, and thus a true detri-
mental effect is unlikely. We also observed positive associ-
ations between advanced disease and intakes of total alcohol
and red wine, although there is limited evidence for an associ-
ation between alcohol and prostate cancer
(36,37,40). Moreover,
our ﬁndings of an inverse association with red/processed
meat and no association with dairy products are in contrast
with previous ﬁndings of an increased risk of prostate cancer
for high intakes of meat and Ca, although the evidence is
inconsistent
(36,37,41,42). The deviating results in our study
may be explained by residual confounding or recall bias, or
may be due to chance, considering that we tested multiple
hypotheses. Another component of the MDS that deserves
attention is the ﬁsh intake. Previous studies on the intake of
fatty ﬁsh rich in n-3 fatty acids have shown inverse associations
with prostate cancer
(43,44), whereas a recent meta-analysis of
the total ﬁsh intake showed no association
(45). The MDS
does not distinguish between fatty and non-fatty ﬁsh, which
may explain the lack of association in our study.
Olive oil is the main source of fat in the Mediterranean
region and was included as a component of the alternative
score, MDS-alt. It has been shown to protect against several
types of cancer
(46,47), but no consistent association has been
found with prostate cancer
(48). We observed no association
between olive oil use and prostate cancer. Due to the generally
low intake of olive oil in the Swedish population at the time of
data collection, this component probably has little overall
inﬂuence on the present results.
The construction of a dietary score as a measure of a healthy
diet is complex, and the MDS is no exception. An inappropriate
scoring method may be unable to detect a true association or
may lead to misclassiﬁcation of exposure. For instance, the
score may be too blunt to detect a weak association with cancer
since it does not capture all dietary aspects or factors unrelated
to diet, or because the beneﬁcial and non-beneﬁcial com-
ponents of the score may counter-balance each other’s potential
effects, leading to a null result. This is a possible explanation for
the overall lack of association seen in the present study. Also,
strong correlations between the score and its components
may inﬂuence the discriminatory power of each individual com-
ponent. In the present study, the estimated inter-correlation
between all components and their correlation with the total
score was low to moderate, which means that each component
contributes equally to the score. An exception was the vegetable
component with a relatively high correlation with the total score
(rs 0·58); hence, it may be the dominant factor determining the
score. Milà-Villarroel et al.
(49) recently evaluated the reliability of
several indexes assessing adherence to the Mediterranean diet,
and the MDS showed high performance.
Using study-speciﬁc intakes, as opposed to externally
deﬁned values, as cut-off between low and high intake
increases the statistical power in each intake group, but it
does not necessarily mean that the score is able to discriminate
between beneﬁcial and non-beneﬁcial health effects. This may
be problematic especially in non-Mediterranean populations
where intake levels may be very different from those of a typi-
cal Mediterranean population. The main differences between
our Swedish study population and the Greek reference popu-
lation were the considerably lower intake of fruit and veg-
etables and higher dairy product intake in the former.
However, the two populations differ not only in nationality
but also in age, the CAPS population being older, and in the
type of exposure data, the Greek data being longitudinal and
prospective whereas the Swedish data were collected only
once and retrospectively. Nevertheless, the observed differ-
ences in intake could indicate a limited discriminatory power
of the MDS in the study population of the present study.
To explore the inﬂuence of using study-speciﬁc intakes as
cut-off values, we compared variants of the MDS with differ-
ent cut-off values, including one score based on the median
intake in a Greek reference population. Overall, we did not
ﬁnd any statistically signiﬁcant association with prostate cancer
for any of the score variants. The non-signiﬁcant increased risk
of disease found with MDS-cent and MDS-greek was unex-
pected, as we had rather anticipated inverse associations.
These results are probably driven by a high vegetable intake,
as the vegetable component had the highest correlation with
the total score and was positively associated with prostate can-
cer risk, especially advanced disease. Since overall we observed
no major differences between the score variants, we suggest
that the use of study-speciﬁc intakes as cut-off values in the
MDS is appropriate also in non-Mediterranean populations.
The usefulness of the MDS in non-Mediterranean populations
is further supported by an Australian study where the MDS was
found to be appropriate for the prediction of survival in both a
population of Mediterranean descent (Greek-Australians) and
a non-Mediterranean population (Anglo-Celts)
(50). Also, in a
European multi-centre cohort study, a two-point increment in
the MDS yielded risk estimates for overall cancer that were simi-
lar in men in Northern and Southern European countries
(51).
We also created an alternative score variant, MDS-alt, to
investigate the effect of a more speciﬁc score that better reﬂects
the ‘original’ Mediterranean diet. Replacing the fat ratio with
olive oil use, cereals with whole grains, meat with red/processed
meat and ethanol with red wine, as well as separating fruits from
nuts, ideally captures the most health-beneﬁcial components of
the Mediterranean diet. Comparing MDS-gram and MDS-alt,
which both used study-speciﬁc median intakes as cut-off values,
we found no statistically signiﬁcant associations for either of
them, the two scores being highly correlated. The non-
statistically signiﬁcantly increased relative risk of advanced pros-
tate cancer seen with MDS-alt is surprising, and may be driven
by the vegetable component as previously discussed, or may be
due to residual confounding.
The inﬂuence of diet on risk of developing prostate cancer
may differ between men who are diagnosed in young or old
age, or between men with and without a family history of
the disease, since the type of prostate cancer and disease mech-
anisms may differ between the groups. We also hypothesised
that diabetic men, as well as overweight or obese men, may
have different metabolic responses to a Mediterranean diet
compared with non-diabetic or normal-weight men. Formal
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for any of these factors. However, in stratiﬁed analyses we
observed positive associations between adherence to the
Mediterranean diet and prostate cancer among men with a
family history of prostate cancer and among obese men, but
not among men without a family history of the disease or
who were non-obese. These results should be interpreted
with caution, especially since the control groups were relatively
small (n 89 for those with a family history of prostate cancer
and n 129 for BMI ≥30 kg/m
2).
The strengths of our study include the large sample size,
high response-rate, the use of population-based random con-
trols, complete and rapid ascertainment of prostate cancer
cases and clinical information on prostate cancer subtypes.
The proportion of prostate-speciﬁc antigen-detected cases
was low (29 % of 1499) due to the low frequency of prostate-
speciﬁc antigen testing at the time of enrolment
(14), ensuring a
high proportion of cases with clinically relevant prostate can-
cer. The risk of confounding by population stratiﬁcation was
minimised by the ethnic homogeneity of the study population.
Also, the extensive questionnaire provided detailed infor-
mation on both exposure and potential confounding factors.
Some limitations with the case–control design need to be
considered in the interpretation of the present results.
Selection bias is possible since cases are generally more
prone to participate than controls, and selection of health-
conscious controls may occur. The retrospective collection
of exposure information may produce recall bias. However,
a previous study comparing original and repeated dietary recall
interviews showed very little or no overall difference in per-
formance between prostate cancer cases and non-cases
(52).
Another drawback is the fact that the FFQ assesses dietary
intake 1 year prior to diagnosis, which may differ from dietary
habits earlier in life, before tumour initiation. Furthermore,
reverse causation bias cannot be ruled out, although men
>60 years generally tend to maintain their dietary habits
even after a cancer diagnosis
(53–55).
Due to limitations in the method for exposure assessment,
measurement error is likely to occur. FFQ generally underes-
timate total energy intake as a result of their inability to capture
the whole diet. The mean and median energy intakes in the
CAPS study population were considerably lower than 10
600 kJ, the recommended daily energy intake for sedentary
men 61–74 years of age
(56), which could indicate an underes-
timation of total food intake. Since energy intake was signiﬁ-
cantly different between cases and controls, differential
misclassiﬁcation of exposure is possible. FFQ may also over-
estimate the usual intake of those food items actually asked
for, leading to distorted estimates of intake
(57), and social
desirability may lead to over-reporting of healthy foods and
under-reporting of unhealthy foods. The validation study of
an FFQ almost identical to the one used in the CAPS study
showed low to moderate correlation for several food
items
(19); however, high correlation coefﬁcients between
FFQ and food records are rarely achieved
(58). Another study
validating a modiﬁed MDS version assessed by an FFQ
against 24-h recalls showed a Pearson’s correlation coefﬁcient
of 0·48, and the average FFQ-based score was 102 % of the
recall-based score
(59). In the present study, the use of
energy-adjusted dietary intake reduces the potential inﬂuence
of bias due to measurement error. Besides, such errors have
less inﬂuence on the ranking of individuals, which is our main
objective, compared with assessment of absolute intake
(57).
The potential effect of any remaining measurement error on
our relative risk estimates is attenuation, which would reduce
the likelihood of detecting a potentially weak diet–disease
relationship
(57); thus it may in part explain the lack of an associ-
ation seen between the Mediterranean diet and prostate cancer.
In conclusion, we found no support for any association
between the Mediterranean dietary pattern and prostate cancer
in the Swedish CAPS study. We have compared several MDS
variants with different compositions and cut-off values, and
observed no signiﬁcant associations with any of the scores.
We suggest that using study-speciﬁc median intakes as cut-off
values as in the original MDS is an appropriate way of assessing
adherence to the Mediterranean diet also in non-Mediterranean
populations. However, the present results, including the unex-
pected associations seen for certain components of the MDS,
need to be cautiously interpreted in light of potential limitations
in the case–control design, the exposure assessment or the dis-
criminatory power of the MDS in our study population.
Further studies are needed to clarify the relationship between
the Mediterranean diet and prostate cancer risk.
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